Pay in 4 interest-free payments of $6.68 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Weight loss injections primarily consist of glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide (marketed as Wegovy for weight management and Ozempic for diabetes) and tirzepatide (Zepbound for weight management, Mounjaro for diabetes)
The cost difference is modest given the clinical effect difference
Help the OAC to raise awareness, advocate for improved access, provide evidence-based education, fight to eliminate weight bias and discrimination and elevate the conversation of weight and its impact on health
Would you let a pharmaceutical company do this
US$ 23.15
US$ 26.02
US$ 26.31
